BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 17021320)

  • 1. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.
    Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D;
    N Engl J Med; 2006 Oct; 355(14):1445-55. PubMed ID: 17021320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.
    Tulic MK; Fiset PO; Christodoulopoulos P; Vaillancourt P; Desrosiers M; Lavigne F; Eiden J; Hamid Q
    J Allergy Clin Immunol; 2004 Feb; 113(2):235-41. PubMed ID: 14767435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy increases CD4+CD25+ T cells in the nasal mucosa of subjects with allergic rhinitis.
    Asai K; Foley SC; Sumi Y; Yamauchi Y; Takeda N; Desrosiers M; Lavigne F; Hamid Q
    Allergol Int; 2008 Dec; 57(4):377-81. PubMed ID: 18797179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults.
    Creticos PS; Maloney J; Bernstein DI; Casale T; Kaur A; Fisher R; Liu N; Murphy K; Nékám K; Nolte H
    J Allergy Clin Immunol; 2013 May; 131(5):1342-9.e6. PubMed ID: 23622121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults.
    Nolte H; Hébert J; Berman G; Gawchik S; White M; Kaur A; Liu N; Lumry W; Maloney J
    Ann Allergy Asthma Immunol; 2013 Jun; 110(6):450-456.e4. PubMed ID: 23706715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local induction of a specific Th1 immune response by allergen linked immunostimulatory DNA in the nasal explants of ragweed-allergic subjects.
    Tulic MK; Christodoulopoulos P; Fiset PO; Vaillancourt P; Lavigne F; Marshall JD; Van Nest G; Eiden JJ; Hamid Q
    Allergol Int; 2009 Dec; 58(4):565-72. PubMed ID: 19776676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind study of the discontinuation of ragweed immunotherapy.
    Naclerio RM; Proud D; Moylan B; Balcer S; Freidhoff L; Kagey-Sobotka A; Lichtenstein LM; Creticos PS; Hamilton RG; Norman PS
    J Allergy Clin Immunol; 1997 Sep; 100(3):293-300. PubMed ID: 9314339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of ragweed sublingual allergy immunotherapy tablets in adults with allergic rhinoconjunctivitis.
    Nayak AS; Atiee GJ; Dige E; Maloney J; Nolte H
    Allergy Asthma Proc; 2012; 33(5):404-10. PubMed ID: 23026182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen.
    Patel P; Holdich T; Fischer von Weikersthal-Drachenberg KJ; Huber B
    J Allergy Clin Immunol; 2014 Jan; 133(1):121-9.e1-2. PubMed ID: 23870670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen.
    Skoner D; Gentile D; Bush R; Fasano MB; McLaughlin A; Esch RE
    J Allergy Clin Immunol; 2010 Mar; 125(3):660-6, 666.e1-666.e4. PubMed ID: 20153030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA.
    Simons FE; Shikishima Y; Van Nest G; Eiden JJ; HayGlass KT
    J Allergy Clin Immunol; 2004 Jun; 113(6):1144-51. PubMed ID: 15208597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy with a ragweed vaccine.
    Simons FE; HayGlass KT
    N Engl J Med; 2007 Jan; 356(1):86-7; author reply 87. PubMed ID: 17205611
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of oral immunotherapy with short ragweed extract.
    Van Deusen MA; Angelini BL; Cordoro KM; Seiler BA; Wood L; Skoner DP
    Ann Allergy Asthma Immunol; 1997 Jun; 78(6):573-80. PubMed ID: 9207721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of IgE-binding to Art v 1, Art v 4 and Amb a 1 in mugwort-allergic patients.
    Oberhuber C; Ma Y; Wopfner N; Gadermaier G; Dedic A; Niggemann B; Maderegger B; Gruber P; Ferreira F; Scheiner O; Hoffmann-Sommergruber K
    Int Arch Allergy Immunol; 2008; 145(2):94-101. PubMed ID: 17823540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis.
    Casale TB; Busse WW; Kline JN; Ballas ZK; Moss MH; Townley RG; Mokhtarani M; Seyfert-Margolis V; Asare A; Bateman K; Deniz Y;
    J Allergy Clin Immunol; 2006 Jan; 117(1):134-40. PubMed ID: 16387596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with a ragweed vaccine.
    Seymour SM; Chowdhury BA
    N Engl J Med; 2007 Jan; 356(1):86; author reply 87. PubMed ID: 17202461
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of risk factors for systemic adverse reactions to SCIT with natural depot allergen extracts: a retrospective study.
    Asero R
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):211-7. PubMed ID: 26549339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study.
    Mirone C; Albert F; Tosi A; Mocchetti F; Mosca S; Giorgino M; Pecora S; Parmiani S; Ortolani C
    Clin Exp Allergy; 2004 Sep; 34(9):1408-14. PubMed ID: 15347374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.